Genmab A/S (GNMSF) Operating cash flow 2023–2025
Genmab A/S (GNMSF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$1.2BFY2025 · since FY2023: $1.1B → $1.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.2B | +5.3% |
| FY2024 | $1.1B | +5.1% |
| FY2023 | $1.1B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GNMSF financial trends
GNMSF RevenueGNMSF Net incomeGNMSF Net marginGNMSF Gross profitGNMSF Gross marginGNMSF Operating incomeGNMSF Operating marginGNMSF Free cash flowGNMSF Capital expendituresGNMSF Return on equityGNMSF Stock buybacksGNMSF Dividends paidGNMSF Total assetsGNMSF Total liabilitiesGNMSF Shareholders’ equityGNMSF overview →